Xperi Holdings Corp. (XPER) to separate its intellectual property business from its core technology products operation. 

CEO Jon Kirchner mentioned during his company's Q4 earnings call that it plans to "separate" its IP unit this fall. 

Update(s):

May 25, 2022: Xperi Holding Corporation (XPER) announced the appointment of Paul E. Davis as Chief Executive Officer of Adeia, the intellectual property (IP) business of Xperi, effective upon completion of its separation as a stand-alone company later this fall.

September 08, 2022: Xperi Holding Corporation (XPER), announced that its Board of Directors has approved the details and timing of the previously announced Spin-Off of the Company’s product business, Xperi from the Company’s IP licensing business, Adeia.

The Board has declared a distribution of the then issued and outstanding shares of common stock, par value $0.001 per share, of Xperi, as a dividend on a pro rata basis to the Company’s stockholders of record as of the close of business on Wednesday, September 21, 2022 (the “Record Date”). 

The Spin-Off is expected to occur on or about October 1, 2022. 

The Company will be renamed Adeia Inc. and is expected to remain trading on the Nasdaq under the new stock symbol “ADEA”

October 3, 2022: Xperi (XPER) completes its spin-off to become an independent public company. As previously announced, each stockholder of record of the company’s predecessor (now known as Adeia Inc.) (ADEA), as of close of business on Wednesday, September 21, 2022, received a distribution of four shares of Xperi Common Stock for every ten shares of common stock of Adeia.

Pfizer Inc. (PFE) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven.

Under the terms of the agreement, Pfizer will acquire all outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven’s non-CGRP development stage pipeline compounds, per Biohaven common share.

The companies expect the transaction to close by early 2023.

Update(s):

September 18, 2022: Biohaven Pharmaceutical Holding Company (BHVN)  announced that it has set a record date of September 26, 2022.

SpinCo common shares are expected to begin regular-way trading on the NYSE under the symbol BHVN on the first trading day following the Distribution Date.

September 22, 2022: Biohaven Ltd. common shares will begin trading on September 23, 2022, on a “when-issued” basis on the New York Stock Exchange under the symbol “BHVN WI” and under “Biohaven Ltd.” “When-issued” trading of Biohaven Ltd. common shares will continue until the spin-off occurs. 

The distribution date for the spin-off is expected to be early in the fourth quarter of 2022, subject to the closing conditions noted in Biohaven’s Proxy Statement filed with the SEC on August 30, 2022, including receipt of shareholder approval at Biohaven’s special meeting of shareholders to be held on September 29, 2022. 

On September 27, 2022, Biohaven Pharmaceutical Holding Company Ltd.  announced that the closing date of the previously announced acquisition of Biohaven by Pfizer Inc. is expected to be on October 3, 2022.

September 30, 2022: Pfizer (PFE) completed its acquisition of Biohaven Pharmaceutical Holding Company.Effective immediately prior to the closing of the acquisition, Biohaven completed the spin-off of Biohaven (BHVN), distributing Biohaven ’s shares to Biohaven’s shareholders. Biohaven Ltd., the new company has retained Biohaven’s non-CGRP development stage pipeline compounds. Pfizer, a Biohaven shareholder, received a pro rata portion of Biohaven Ltd.’s shares in the distribution and owns approximately 3% of Biohaven Ltd. The company will continue to trade on the New York Stock Exchange under the ticker “BHVN”.

Following a decision by its Board of Directors, ABB (ABB) announces its intention to spin off Accelleron (formerly ABB Turbocharging), its market-leading turbocharging division, by way of a dividend in kind of Accelleron Industries Ltd’s shares to ABB’s shareholders. Accelleron’s listing on SIX Swiss Exchange in Zurich is planned for October 3, 2022, and is subject to, among others, approval by ABB’s shareholders at an Extraordinary General Meeting scheduled for September 7, 2022.

Update(s):

September 7, 2022:

The shareholders of ABB approved the proposed spin-off of its Accelleron turbocharging division at today’s Extraordinary General Shareholders Meeting of ABB Ltd (ABB) held in Zurich. ABB will distribute to its shareholders, on a pro rata basis, as a dividend in kind, 1 Accelleron share for 20 ABB Ltd shares held. 

Accelleron’s listing on SIX Swiss Exchange in Zurich is planned for October 3, 2022. ABB plans to publish Accelleron’s listing prospectus on September 23, 2022.

October 3, 2022: ABB (ABB) announces that Accelleron Industries AG (formerly ABB Turbocharging), has been admitted to start trading on SIX Swiss Exchange in Zurich under the ticker symbol “ACLN”, marking the completion of Accelleron’s spin-off from ABB. 

Harley-Davidson, Inc. (HOG), the world’s most desirable motorcycle company, and AEA-Bridges Impact Corp. (IMPX), a special purpose acquisition company with a dedicated sustainability focus, sponsored by executives of AEA Investors and Bridges Fund Management, announced that they have entered into a definitive business combination agreement under which ABIC will combine with LiveWire, Harley-Davidson’s electric motorcycle division, to create a new publicly traded company. Its common stock is expected to be listed on the New York Stock Exchange under the symbol “LVW”.

Update(s):

September 27, 2022: Harley-Davidson, Inc. (HOG), and AEA-Bridges Impact (IMPX), a special purpose acquisition company announced the completion of their previously announced business combination under which LiveWire EV, LLC, Harley-Davidson's electric motorcycle division, combined with ABIC, to create a new public company.

NEOGEN Corporation (NEOG) and 3M (MMM) announced that they have entered into a definitive agreement pursuant to which 3M will separate its Food Safety business and simultaneously combine it with NEOGEN in a transaction that is intended to be tax-efficient to 3M and its shareholders for U.S. federal income tax purposes.

Update(s):

July 26, 2022: 3M intends to complete the transaction through a split-off with a targeted closing date of September 1, 2022, subject to approval by Neogen shareholders, receipt of required regulatory approvals and the satisfaction of other customary closing conditions.

September 1, 2022: 3M (MMM) announced both the successful completion of its split-off exchange offer for 3M common stock in connection with the previously announced separation of 3M's food safety business and the closing of the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary holding the food safety business, with a subsidiary of Neogen Corporation ("Neogen"). Pursuant to the merger, SpinCo is now a wholly-owned subsidiary of Neogen.

February 9, 2021: América Móvil (AMX) announced that its Board of Directors approved a plan to spin-off from América Móvil the telecommunications towers and other related passive infrastructure in Latin American countries where it currently operates.

Update(s):

September 29, 2021: Shareholders approved a plan of America Movil (AMX), controlled by the family of billionaire Carlos Slim, to spin off its towers business in Latin America, Mexico's biggest telecoms company said.

April 28, 2022: Carlos Garcia Moreno – Chief Financial Officer during América Móvil (AMX) Q1 earnings mentioned that Sitios Latinoamerica upon its spinoff from América Móvil expected to take place in the third quarter.

August 8, 2022: Mexican telecommunications giant America Movil (AMX) said it had completed the planned spinoff of its Latin American cellular tower business, creating a company called Sitios Latinoamerica.

Xperi Holdings Corp. (XPER) to separate its intellectual property business from its core technology products operation. 

CEO Jon Kirchner mentioned during his company's Q4 earnings call that it plans to "separate" its IP unit this fall. 

Update(s):

May 25, 2022: Xperi Holding Corporation (XPER) announced the appointment of Paul E. Davis as Chief Executive Officer of Adeia, the intellectual property (IP) business of Xperi, effective upon completion of its separation as a stand-alone company later this fall.

September 08, 2022: Xperi Holding Corporation (XPER), announced that its Board of Directors has approved the details and timing of the previously announced Spin-Off of the Company’s product business, Xperi from the Company’s IP licensing business, Adeia.

The Board has declared a distribution of the then issued and outstanding shares of common stock, par value $0.001 per share, of Xperi, as a dividend on a pro rata basis to the Company’s stockholders of record as of the close of business on Wednesday, September 21, 2022 (the “Record Date”). 

The Spin-Off is expected to occur on or about October 1, 2022. 

The Company will be renamed Adeia Inc. and is expected to remain trading on the Nasdaq under the new stock symbol “ADEA”

October 3, 2022: Xperi (XPER) completes its spin-off to become an independent public company. As previously announced, each stockholder of record of the company’s predecessor (now known as Adeia Inc.) (ADEA), as of close of business on Wednesday, September 21, 2022, received a distribution of four shares of Xperi Common Stock for every ten shares of common stock of Adeia.

Pfizer Inc. (PFE) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven.

Under the terms of the agreement, Pfizer will acquire all outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven’s non-CGRP development stage pipeline compounds, per Biohaven common share.

The companies expect the transaction to close by early 2023.

Update(s):

September 18, 2022: Biohaven Pharmaceutical Holding Company (BHVN)  announced that it has set a record date of September 26, 2022.

SpinCo common shares are expected to begin regular-way trading on the NYSE under the symbol BHVN on the first trading day following the Distribution Date.

September 22, 2022: Biohaven Ltd. common shares will begin trading on September 23, 2022, on a “when-issued” basis on the New York Stock Exchange under the symbol “BHVN WI” and under “Biohaven Ltd.” “When-issued” trading of Biohaven Ltd. common shares will continue until the spin-off occurs. 

The distribution date for the spin-off is expected to be early in the fourth quarter of 2022, subject to the closing conditions noted in Biohaven’s Proxy Statement filed with the SEC on August 30, 2022, including receipt of shareholder approval at Biohaven’s special meeting of shareholders to be held on September 29, 2022. 

On September 27, 2022, Biohaven Pharmaceutical Holding Company Ltd.  announced that the closing date of the previously announced acquisition of Biohaven by Pfizer Inc. is expected to be on October 3, 2022.

September 30, 2022: Pfizer (PFE) completed its acquisition of Biohaven Pharmaceutical Holding Company.Effective immediately prior to the closing of the acquisition, Biohaven completed the spin-off of Biohaven (BHVN), distributing Biohaven ’s shares to Biohaven’s shareholders. Biohaven Ltd., the new company has retained Biohaven’s non-CGRP development stage pipeline compounds. Pfizer, a Biohaven shareholder, received a pro rata portion of Biohaven Ltd.’s shares in the distribution and owns approximately 3% of Biohaven Ltd. The company will continue to trade on the New York Stock Exchange under the ticker “BHVN”.

Following a decision by its Board of Directors, ABB (ABB) announces its intention to spin off Accelleron (formerly ABB Turbocharging), its market-leading turbocharging division, by way of a dividend in kind of Accelleron Industries Ltd’s shares to ABB’s shareholders. Accelleron’s listing on SIX Swiss Exchange in Zurich is planned for October 3, 2022, and is subject to, among others, approval by ABB’s shareholders at an Extraordinary General Meeting scheduled for September 7, 2022.

Update(s):

September 7, 2022:

The shareholders of ABB approved the proposed spin-off of its Accelleron turbocharging division at today’s Extraordinary General Shareholders Meeting of ABB Ltd (ABB) held in Zurich. ABB will distribute to its shareholders, on a pro rata basis, as a dividend in kind, 1 Accelleron share for 20 ABB Ltd shares held. 

Accelleron’s listing on SIX Swiss Exchange in Zurich is planned for October 3, 2022. ABB plans to publish Accelleron’s listing prospectus on September 23, 2022.

October 3, 2022: ABB (ABB) announces that Accelleron Industries AG (formerly ABB Turbocharging), has been admitted to start trading on SIX Swiss Exchange in Zurich under the ticker symbol “ACLN”, marking the completion of Accelleron’s spin-off from ABB. 

Harley-Davidson, Inc. (HOG), the world’s most desirable motorcycle company, and AEA-Bridges Impact Corp. (IMPX), a special purpose acquisition company with a dedicated sustainability focus, sponsored by executives of AEA Investors and Bridges Fund Management, announced that they have entered into a definitive business combination agreement under which ABIC will combine with LiveWire, Harley-Davidson’s electric motorcycle division, to create a new publicly traded company. Its common stock is expected to be listed on the New York Stock Exchange under the symbol “LVW”.

Update(s):

September 27, 2022: Harley-Davidson, Inc. (HOG), and AEA-Bridges Impact (IMPX), a special purpose acquisition company announced the completion of their previously announced business combination under which LiveWire EV, LLC, Harley-Davidson's electric motorcycle division, combined with ABIC, to create a new public company.

NEOGEN Corporation (NEOG) and 3M (MMM) announced that they have entered into a definitive agreement pursuant to which 3M will separate its Food Safety business and simultaneously combine it with NEOGEN in a transaction that is intended to be tax-efficient to 3M and its shareholders for U.S. federal income tax purposes.

Update(s):

July 26, 2022: 3M intends to complete the transaction through a split-off with a targeted closing date of September 1, 2022, subject to approval by Neogen shareholders, receipt of required regulatory approvals and the satisfaction of other customary closing conditions.

September 1, 2022: 3M (MMM) announced both the successful completion of its split-off exchange offer for 3M common stock in connection with the previously announced separation of 3M's food safety business and the closing of the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary holding the food safety business, with a subsidiary of Neogen Corporation ("Neogen"). Pursuant to the merger, SpinCo is now a wholly-owned subsidiary of Neogen.

February 9, 2021: América Móvil (AMX) announced that its Board of Directors approved a plan to spin-off from América Móvil the telecommunications towers and other related passive infrastructure in Latin American countries where it currently operates.

Update(s):

September 29, 2021: Shareholders approved a plan of America Movil (AMX), controlled by the family of billionaire Carlos Slim, to spin off its towers business in Latin America, Mexico's biggest telecoms company said.

April 28, 2022: Carlos Garcia Moreno – Chief Financial Officer during América Móvil (AMX) Q1 earnings mentioned that Sitios Latinoamerica upon its spinoff from América Móvil expected to take place in the third quarter.

August 8, 2022: Mexican telecommunications giant America Movil (AMX) said it had completed the planned spinoff of its Latin American cellular tower business, creating a company called Sitios Latinoamerica.